[{"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "1 vial", "code_info": "Lot # t12-12-2016@87, Exp 5/22/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 45.45/27.27/0.45 5ML MDV MCG/MG/MG/ML INJ, Injection, 45.45mcg/27.27mg/0.45mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0749-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["DIPHENHYDRAMINE HYDROCHLORIDE"], "generic_name": ["DIPHENHYDRAMINE HYDROCHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-2056", "0904-5306", "0904-2035"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["DIPHENHYDRAMINE HYDROCHLORIDE"], "rxcui": ["1020477", "1049909", "1092422"], "spl_id": ["3c444aaf-9ca2-9349-e063-6294a90a4a89"], "spl_set_id": ["04e70311-6412-4a20-84e3-f6e26d5f19ab"], "package_ndc": ["0904-5306-60", "0904-5306-80", "0904-5306-61", "0904-5306-24", "0904-2056-61", "0904-2035-24"], "is_original_packager": [true], "unii": ["TC2D6JAD40"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0512-2021", "product_description": "Banophen  Diphenhydramine HCl 25 mg Antihistamine 100 capsules NDC 0904-5306-60 Distributed by: Major Pharmaceuticals 31778 Enterprise Drive Livonia, MI 48150 USA", "product_quantity": "88 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88905", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0611-2022", "product_description": "Severe Congestion Nasal Spray, No Drip Plus Menthol, Oxymetazoline HCl 0.05%, 1 FL Oz (30 mL) per bottle,  Dist. by Target Corp., Mpls., MN 55403. NDC 11673-935-10", "product_quantity": "89,208 bottles", "reason_for_recall": "CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.", "recall_initiation_date": "20211026", "center_classification_date": "20220223", "termination_date": "20230929", "report_date": "20220302", "code_info": "Batch: 1BK0912, Exp 12/31/2022; 1FK1251, Exp 02/28/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-120-2014", "product_description": "HCG 220 iu prefilled syringes, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1881 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Brooklyn", "address_1": "908 Dean St", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.", "address_2": "", "product_quantity": "17 boxes", "code_info": "All lots", "center_classification_date": "20160711", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NY", "product_description": "Te Xiao BaiNeiTing Herbal Supplement (Naphazoline HCl Solution 0.1%) liquid, Net Wt. 15ml, packaged in a bottle within a box, Produced by: Good Harvests (Asia) Trading Co., Ltd, Imported by Murray Int'l Trading Co., Inc. New York, NY 10013, UPC 7 67533 86115 6, remaining labeling contains Chinese characters.", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Murray International Trading Co., Inc.", "recall_number": "D-1357-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "74017", "termination_date": "20180614", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "11238-3204", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0279-2018", "product_description": "Medline Laceration Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "600 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDL1688; Lots: 17HB3112", "more_code_info": ""}, {"status": "Terminated", "city": "Canoga Park", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "72830", "recalling_firm": "Reesna, Inc", "address_1": "7921 Canoga Ave Ste I", "address_2": "N/A", "postal_code": "91304-5021", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and United Kingdom", "recall_number": "D-0959-2016", "product_description": "FUEL UP PLUS, capsules, a) 1-count package, b) 5-count bottle, c) 10-count bottle  WWW.FUELUPPILLS.COM", "product_quantity": "26,250 capsules", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: Products were found to be tainted with undeclared hydroxythiohomosildenafil, an analogue of Sildenafil, an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making them unapproved new drugs.", "recall_initiation_date": "20151211", "center_classification_date": "20160606", "termination_date": "20160609", "report_date": "20160615", "code_info": "Exp. 12/18"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA021148"], "brand_name": ["NORDITROPIN"], "generic_name": ["SOMATROPIN"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-7703", "0169-7704", "0169-7705", "0169-7708"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["SOMATROPIN"], "rxcui": ["847243", "847245", "847247", "847348", "849850", "849851", "1736262", "1736329"], "spl_id": ["b67c2419-4feb-4ce1-b97e-88760a8e1aee"], "spl_set_id": ["1058e17c-9261-459c-a3e6-fae38d196c14"], "package_ndc": ["0169-7704-21", "0169-7704-92", "0169-7705-21", "0169-7705-92", "0169-7708-21", "0169-7708-92", "0169-7703-11", "0169-7703-91", "0169-7703-21", "0169-7703-92"], "is_original_packager": [true], "nui": ["N0000175606", "M0028842"], "pharm_class_epc": ["Recombinant Human Growth Hormone [EPC]"], "pharm_class_cs": ["Human Growth Hormone [CS]"], "unii": ["NQX9KB6PCL"]}, "product_type": "Drugs", "event_id": "74044", "recalling_firm": "Novo Nordisk Inc", "address_1": "1100 Campus Rd", "address_2": "N/A", "postal_code": "08540-6650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0956-2016", "product_description": "Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only,  Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7703-21", "product_quantity": "723 pens", "reason_for_recall": "Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called \"air shot\" step", "recall_initiation_date": "20160427", "center_classification_date": "20160606", "termination_date": "20170502", "report_date": "20160615", "code_info": "Lot Number FC70222"}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0278-2018", "product_description": "Medline General Purpose Tray, Sterile, Single Use Only. Packaged in USA for Medline Industries, Inc., Mundelein, IL 60060", "product_quantity": "56 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYNDL1648; Lots: 17FA0144", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021929"], "brand_name": ["BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE"], "generic_name": ["BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0310-7370", "0310-7372"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["BUDESONIDE", "FORMOTEROL FUMARATE"], "rxcui": ["1246288", "1246304"], "spl_id": ["dd03d461-e832-4b70-a540-a70fbbfd87f9"], "spl_set_id": ["1d266fe8-52e3-4f85-a037-c5c1afa15e60"], "package_ndc": ["0310-7370-20", "0310-7372-20"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X", "W34SHF8J2K"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0561-2021", "product_description": "Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol 80/4.5 budesonide 80 mcg/formoterol fumarate dihydrate 4.5 mcg Inhalation Aerosol 120 inhalations Rx only Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, NDC 0310-7372-20", "product_quantity": "905 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2000655C00"}, {"status": "Terminated", "city": "Cambridge", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["ANDA088390"], "brand_name": ["LIDOCAINE", "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"], "generic_name": ["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"], "manufacturer_name": ["Darby Dental Supply, LLC", "IQ Dental"], "product_ndc": ["66467-9730", "42756-1030"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBMUCOSAL"], "substance_name": ["EPINEPHRINE BITARTRATE", "LIDOCAINE HYDROCHLORIDE"], "rxcui": ["1293648"], "spl_id": ["e017e74c-d217-472f-be32-7d21d7f129ec", "00e156a7-2bd7-48a3-b87f-957792c307f5"], "spl_set_id": ["e5ed4c2a-e320-48cf-a2fd-61d48481c624", "b1b09a84-7978-4380-9c40-a4bf837be637"], "package_ndc": ["66467-9730-5", "42756-1030-5", "0362-9023-05"], "is_original_packager": [true], "unii": ["30Q7KI53AK", "V13007Z41A"]}, "product_type": "Drugs", "event_id": "65979", "recalling_firm": "Novocol Pharmaceutical of Canada", "address_1": "25 Wolseley Court", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Canada", "recall_number": "D-923-2013", "product_description": "Lidocaine Hydrochloride 2% and Epinephrine 1:100,000 Injection, Rx Only, For Dental Block and Infiltration Only, 50 Cartridges per box - 1.7 mL minimum each,  NDC #s: a) Octocaine 100, Mfr'ed for Septodont, Louisville, CO, 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, Ontario, Canada N1R6X3, 0362-9023-05; b) Superdent, Dist by: Darby Dental Supply Co., Jericho, NY 11753, Made in Canada,  66467-9730-5; and c) Dist by: IQ Dental, 353 Rt 46 W, Bldg C Unit 120, Fairfield, NJ, 07004, made in Canada, 42756-1030-5; Manufactured by: by Novocol Pharmaceutical of Canada, Inc., Cambridge, Ontario, Canada N1R6X3.", "product_quantity": "12,497 Boxes", "reason_for_recall": "Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1:100,000 Injectable, distributed under the names: Octocaine 100, and 2% Xylocaine Dental, may be subpotent for the epinephrine component.", "recall_initiation_date": "20130814", "center_classification_date": "20130826", "termination_date": "20140107", "report_date": "20130904", "code_info": "Lot #s: D00290 D, Exp 08/2013; D00205 A, Exp 11/2013", "more_code_info": ""}, {"status": "Terminated", "city": "Tonawanda", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91972", "recalling_firm": "Pine Pharmaceuticals, LLC", "address_1": "355 Riverwalk Pkwy", "address_2": "N/A", "postal_code": "14150-5837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0531-2023", "product_description": "Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging).  Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150,  Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1", "product_quantity": "932 syringes", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.", "recall_initiation_date": "20230327", "center_classification_date": "20230413", "termination_date": "20230601", "report_date": "20230419", "code_info": "Lot # 66377, Exp. Date: 06/28/2023. Syringe may be labeled incorrectly as lot# 66316"}, {"status": "Ongoing", "city": "Juno Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75763", "recalling_firm": "Tri-Coast Pharmacy", "address_1": "14125 US Highway 1", "address_2": "N/A", "postal_code": "33408-1425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0299-2017", "product_description": "Testosterone Cypionate in Grapeseed, 200 mg/mL, (5 ML and 10 ML).  Compounded by Tri-Coast Pharmacy", "product_quantity": "2,818 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20161117", "center_classification_date": "20170104", "report_date": "20170111", "code_info": "Recall includes all sterile products compounded between 05/17/2016 and 11/17/2016.    Known lot codes (Exp Date): 05232016D (11/19/2016), 06162016A (12/13/2016), 06132016A (12/10/2016), 07282016I (01/24/2017), 08172016D (02/13/2017), 08042016C (01/31/2017), 09222016F (03/21/2017), 09062016A (02/28/2017), 10272016B (02/28/2017), 10252016D (02/28/2017), 08252016B (02/21/2017), 11022016C (05/01/2017)."}, {"country": "United States", "city": "Boca Raton", "address_1": "1140 Holland Dr", "reason_for_recall": "Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.", "address_2": "Ste 12", "product_quantity": "150 bottles", "code_info": "All lots remaining within expiry.", "center_classification_date": "20170912", "distribution_pattern": "Florida", "state": "FL", "product_description": "ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg) capsule, packaged in 60-count bottle, Andropharm.com, UPC: 6 42125 50294 8", "report_date": "20170920", "classification": "Class I", "openfda": {}, "recalling_firm": "Andropharm, LLC", "recall_number": "D-1142-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "77664", "termination_date": "20200602", "recall_initiation_date": "20170606", "postal_code": "33487-2764", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA019414"], "brand_name": ["CARDIOGEN-82"], "generic_name": ["RUBIDIUM CHLORIDE RB-82"], "manufacturer_name": ["Bracco Diagnostics Inc"], "product_ndc": ["0270-0091"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["RUBIDIUM CHLORIDE RB-82"], "spl_id": ["990b8a5b-d1f5-2119-1e01-cdccdcb607ba"], "spl_set_id": ["ee95aa18-9f2f-40eb-9b4c-583bea6f36bf"], "package_ndc": ["0270-0091-01"], "is_original_packager": [true], "unii": ["F0Z746KRKQ"]}, "product_type": "Drugs", "event_id": "62866", "recalling_firm": "Bracco Diagnostics Inc", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and United Kingdom", "recall_number": "D-1684-2012", "product_description": "CARDIOGEN-82 (Rubidium Rb 82 Generator), 140 millicurie, Rx Only, For Elution of sterile nonpyrogenic Rubidium Chloride Rb 82, Manufactured for: Bracco Diagnostics Inc. Princeton, NJ 08543 by Medi-Physics, Inc. South Plainfield, NJ 07080, NDC 0270-0091-01", "product_quantity": "54 generators", "reason_for_recall": "GMP deviation; Sr-82 levels exceeded alert limit specification", "recall_initiation_date": "20120601", "center_classification_date": "20120921", "termination_date": "20130318", "report_date": "20121003", "code_info": "Lot numbers 09101-121251 and 09101-121391", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0431-2022", "product_description": "CSF Otic Insufflation Capsule, Sulfacetamide Sodium/ Ciprofloxacin/ Amphotericin B Otic Powder, 50mg / 30mg / 5mg, 5 count bottle, For Otic Use with Insufflator, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1633-05", "product_quantity": "1055 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "10-2021-27@8 01-25-2022", "more_code_info": ""}, {"status": "Terminated", "city": "Cambridge", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA125291"], "brand_name": ["LUMIZYME"], "generic_name": ["ALGLUCOSIDASE ALFA"], "manufacturer_name": ["Genzyme Corporation"], "product_ndc": ["58468-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALGLUCOSIDASE ALFA"], "rxcui": ["629568", "993072"], "spl_id": ["26b8bca9-7139-453b-afaa-2474ca711fc2"], "spl_set_id": ["d6bfbc45-2d34-439e-8aad-59ee2d53d4df"], "package_ndc": ["58468-0160-1", "58468-0160-2"], "is_original_packager": [true], "nui": ["M0000794", "N0000175821"], "pharm_class_cs": ["alpha-Glucosidases [CS]"], "pharm_class_epc": ["Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]"], "unii": ["DTI67O9503"]}, "product_type": "Drugs", "event_id": "72929", "recalling_firm": "Genzyme Corporation", "address_1": "500 Kendall Street", "address_2": "675 West Kendall/55 Cambridge Parkway", "postal_code": "02142-1108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "TN", "recall_number": "D-0799-2016", "product_description": "Lumizyme (alglucosidase alpha), 50 mg/vial, For Intravenous Infusion Only, Rx Only, Manufactured by Genzyme Corportation, Cambridge, MA 02142, NDC 58468-0160-1", "product_quantity": "24 vials", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20151208", "center_classification_date": "20160331", "termination_date": "20160801", "report_date": "20160406", "code_info": "Lot # C5370C02; Exp. 02/18"}, {"status": "Terminated", "city": "Bristol", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82554", "recalling_firm": "Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy", "address_1": "Attn: Cleve Anderson", "address_2": "310 Bluff City Hwy", "postal_code": "37620-4602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1178-2019", "product_description": "Serum Tears 30% Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.", "product_quantity": "60 drop containers", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190402", "center_classification_date": "20190418", "termination_date": "20210924", "report_date": "20190424", "code_info": "All Lots"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-628-2015", "product_description": "Dextran-70 active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Atlanta", "address_1": "6 Concourse Pkwy", "reason_for_recall": "Defective Container: Incomplete seal on blister packaging, leading to tablet swelling and enlarging due to effervescence process beginning as oxygen and moisture enter the blister packaging.", "address_2": "Suite 1800", "product_quantity": "16,932 cartons", "code_info": "Lot numbers: 005C16, 006C16, 007C16, Exp 02/2018", "center_classification_date": "20161014", "distribution_pattern": "CA, FL, GA, LA, MO, MS, NC, OH, PA, SC, TN, TX, VA and WV.", "state": "GA", "product_description": "Cetylev (acetylcysteine) effervescent tablets for oral solution, 500 mg, Rx Only, 20 tablets per carton (ten 2 count blister packs), Distributed by Arbor Pharmaceuticals, LLC Atlanta, GA 30328, NDC 24338-700-10.", "report_date": "20161026", "classification": "Class I", "openfda": {}, "recalling_firm": "Arbor Pharmaceuticals Inc.", "recall_number": "D-0105-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74857", "termination_date": "20170123", "recall_initiation_date": "20160721", "postal_code": "30328-6117", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-514-2015", "product_description": "Aminophylline active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "11600 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["NDA020161"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["ICU Medical Inc."], "product_ndc": ["0990-7074", "0990-7075", "0990-7077"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["312507", "1860239", "1860241", "1860463", "1860466"], "spl_id": ["88bcbbe4-9ebf-4491-874a-c4c4c7f1f90d"], "spl_set_id": ["eb56a807-ea94-4edb-9811-a04b19568468"], "package_ndc": ["0990-7074-26", "0990-7075-14", "0990-7075-26", "0990-7077-14", "0990-7077-26", "0030990707", "3030990707"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "96250", "recalling_firm": "ICU Medical, Inc.", "address_1": "600 N Field Dr", "address_2": "", "postal_code": "60045-4835", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0267-2025", "product_description": "POTASSIUM CHLORIDE Inj., 20 mEq total in 100 mL flexible container 24 x case, 200 mEq/L, Rx Only, ICU Medical, Inc., Lake Forest, Illinois, 60045, USA, NDC# 0990-7075-26; Bar Code Flexible container (01) 00309907075266; Case (01)30309907075267", "product_quantity": "67,488 flexible containers", "reason_for_recall": "Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20 mEq is printed on the labeling affixed to the product flexible container.", "recall_initiation_date": "20250213", "center_classification_date": "20250310", "report_date": "20250319", "code_info": "Lot 1023172, Exp Date: 31 January 2026", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SOTALOL HCL, Tablet, 120 mg may have potentially been mislabeled as the following drug:  NEOMYCIN SULFATE, Tablet, 500 mg, NDC 51991073801, Pedigree: AD49448_17, EXP: 5/17/2014.", "address_2": "", "product_quantity": "101 Tablets", "code_info": "SOTALOL HCL, Tablet, 120 mg has the following codes:   Pedigree: AD49448_20 EXP: 5/17/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SOTALOL HCL, Tablet, 120 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093106001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-832-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Newtown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040886"], "brand_name": ["PHENTERMINE HYDROCHLORIDE"], "generic_name": ["PHENTERMINE HYDROCHLORIDE"], "manufacturer_name": ["KVK-Tech, Inc."], "product_ndc": ["10702-026", "10702-027", "10702-028"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PHENTERMINE HYDROCHLORIDE"], "rxcui": ["900038", "968766"], "spl_id": ["1662a72d-c285-b644-e063-6294a90a7333"], "spl_set_id": ["b963f7bb-fa65-4e28-81c9-282fbe70a6a6"], "package_ndc": ["10702-026-03", "10702-026-01", "10702-026-10", "10702-027-03", "10702-027-01", "10702-027-10", "10702-028-03", "10702-028-01", "10702-028-10"], "is_original_packager": [true], "upc": ["0310702027107", "0310702028104", "0310702026100"], "unii": ["0K2I505OTV"]}, "product_type": "Drugs", "event_id": "96847", "recalling_firm": "KVK Tech, Inc.", "address_1": "110 Terry Dr", "address_2": "N/A", "postal_code": "18940-3427", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0446-2025", "product_description": "Phentermine Hydrochloride Capsules, USP 30mg, 100-count bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-028-01.", "product_quantity": "9680 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250509", "center_classification_date": "20250521", "report_date": "20250528", "code_info": "Lot#: 18350A, 18351A,  Exp 6/30/2027"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84213", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide throughout the United States, Canada and Saudi Arabia", "recall_number": "D-0505-2020", "product_description": "StellaLife VEGA Oral Gel Rinse (In equal parts of: Azadirachta Indica 1x, Calendula Officinalis 1x, Echinacea Purpurea 1x, Plantago Major 1x), packaged in 1000 mL white plastic bottle.", "product_quantity": "1 bottle/", "reason_for_recall": "CGMP Deviations: products were not manufactured under current good manufacturing practices.", "recall_initiation_date": "20191108", "center_classification_date": "20191118", "termination_date": "20230104", "report_date": "20191127", "code_info": "Lot # 29488"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0942-2020", "product_description": "BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [2ML] 6MG/ML INJ SUSP, For IM, IA, IT Use, Shake Well. Preservative Free. Discard Unused Portion, 2 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0620-2", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 10022019+53004, Exp 2/28/2020; 11252019+53282, Exp 6/12/2020"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0032-2022", "product_description": "ASCORBIC ACID (NON-CORN) 500MG/ML SOLN (PF), Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Roseburg", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81883", "recalling_firm": "Hiers Enterprises, LLC dba Northwest Compounding Pharmacy", "address_1": "1350 Ne Stephens St Ste 42", "address_2": "N/A", "postal_code": "97470-6410", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients.    These are compounded products - labels vary for each compound - specific to each patient.  Firm did not provide labeling.", "recall_number": "D-0393-2019", "product_description": "Epinephrine liquid 1:1000, RX, glass vial", "product_quantity": "50 ml", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20190102", "center_classification_date": "20190127", "termination_date": "20230328", "report_date": "20190109", "code_info": "10102018@13 exp 1/8/19,    10222018@33 exp 1/20/19,"}, {"status": "Terminated", "city": "Oberasbach", "state": "N/A", "country": "Germany", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77840", "recalling_firm": "Linde Eckstein Gmbh + Co KG", "address_1": "Flurstrasse 27a-35", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed throughout the United States", "recall_number": "D-1110-2017", "product_description": "Make Up Perfect terra (Titanium Dioxide) SPF 10 liquid make-up, 1 oz. Net Wt. 30 ml bottle, Art. 03350, Made in Germany, Doctor Eckstein, Linde Eckstein GMBH Co. Kg, 90522 Oberasbach, Germany, UPC 4 035219 033507.", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.", "recall_initiation_date": "20170717", "center_classification_date": "20170817", "termination_date": "20180228", "report_date": "20170823", "code_info": "Lot #: 221217, Exp 12/22/2017; 270718, Exp 07/27/2018."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup:predniSONE, Tablet, 20 mg may have potentially been mislabeled as the following drug:   methylPREDNISolone, Tablet, 4 mg, NDC 00781502201, Pedigree: AD54587_7, EXP: 5/21/2014.", "address_2": "", "product_quantity": "603 Tablets", "code_info": "predniSONE, Tablet, 20 mg has the following codes:   Pedigree:  AD56879_5, EXP: 5/21/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "predniSONE, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591544301.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-976-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0164-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 2MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1007142021:50 BUD: 01/10/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Weston", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206355"], "brand_name": ["LACOSAMIDE ORAL SOLUTION"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0405"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "rxcui": ["993856"], "spl_id": ["dec292bf-788d-95ae-e305-7b2ca242ffc3"], "spl_set_id": ["6fb99b0c-d937-f095-513b-b2c561047abf"], "package_ndc": ["60505-0405-6", "60505-0405-4"], "is_original_packager": [true], "upc": ["0360505040544"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "96953", "recalling_firm": "Apotex Corp.", "address_1": "2400 N Commerce Pkwy Ste 400", "address_2": "N/A", "postal_code": "33326-3253", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide.", "recall_number": "D-0457-2025", "product_description": "Lacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston FL 33326, NDC 60505-0405-4", "product_quantity": "20,648 bottles", "reason_for_recall": "Defective Container: This recall is being initiated due to a leaking unit stored horizontally.", "recall_initiation_date": "20250528", "center_classification_date": "20250603", "report_date": "20250611", "code_info": "Batch # TZ5589, Exp Date: 01/31/2026"}, {"country": "United States", "city": "Harriman", "address_1": "144 Route 17m Ste 4", "reason_for_recall": "Penicillin Cross Contamination: potentially contaminated with penicillin", "address_2": "", "product_quantity": "unknown", "code_info": "All lots", "center_classification_date": "20151202", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "ESTRIOL Gels, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Life Science Pharmacy Inc", "recall_number": "D-0495-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71494", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20150608", "postal_code": "10926-3321", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82718", "recalling_firm": "Advanced Pharma Inc.", "address_1": "9265 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the US", "recall_number": "D-1251-2019", "product_description": "HYDROmorphone 20 mg/100 mL Injectable Solution, Hydromorphone HCl 20 mg 0.9% Sodium Chloride 100 mL, Sterile single use bag, Compounded Drug, Avella of Houston 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404, NDC: 42852-221-10", "product_quantity": "560 bags", "reason_for_recall": "Sub-potency", "recall_initiation_date": "20190426", "center_classification_date": "20190429", "termination_date": "20191030", "report_date": "20190508", "code_info": "Lot: 01/14/19 0215 22110P Exp. 04/29/2019"}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "2 vials", "code_info": "Lot # t02-02-2017@93, Exp 8/2/2017", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "TRI MIX 40/30/2 5ML MDV MCG/MG/MG/ML INJ, Injection, 40mcg/30mg/2mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0747-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0789-2019", "product_description": "Dr. King's SafeCare Rx Eating Disorders, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955000129, NDC 57955-0001-2", "product_quantity": "17 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 040606L Exp. 04/19"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: SIMVASTATIN, Tablet, 5 mg may have potentially been mislabeled as the following drug:  LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 13668011390, Pedigree: AD65323_10, EXP: 5/29/2014.", "address_2": "", "product_quantity": "90 Tablets", "code_info": "SIMVASTATIN, Tablet, 5 mg has the following codes:   Pedigree: AD65323_13, EXP: 5/29/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "SIMVASTATIN, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093715298.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-841-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0716-2021", "product_description": "HYDROMORPHONE HCL-BUPIVACAINE HCL-SUFENTANIL PF 25MG-9MG-110MCG/ML INJECTABLE 21 mL syringe, Rx only,  Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "21 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: 09292020@59  BUD 10/28/2020"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0075-2015", "product_description": "Cyclosporine/corn oil stock vehicle oil packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "100 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06262014@39, Exp 9/24/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M016"], "brand_name": ["A AND D ORIGINAL"], "generic_name": ["LANOLIN AND PETROLATUM"], "manufacturer_name": ["Bayer HealthCare LLC."], "product_ndc": ["11523-0096"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["LANOLIN", "PETROLATUM"], "rxcui": ["664981", "705895"], "spl_id": ["289dd4d1-becd-42a7-e063-6394a90ace68"], "spl_set_id": ["13abe949-c5ba-4610-8cc2-ac9d2eb32520"], "package_ndc": ["11523-0096-7", "11523-0096-3"], "is_original_packager": [true], "upc": ["0041100811349"], "unii": ["7EV65EAW6H", "4T6H12BN9U"]}, "product_type": "Drugs", "event_id": "90553", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1322-2022", "product_description": "A&D Original Ointment, Diaper Rash Ointment & Skin Protectant, 16 oz. Jar, Bayer Healthcare Pharmaceutica, NDC 11523-0096-3.", "product_quantity": "1 Jar", "reason_for_recall": "CGMP Deviations: products were stored outside the drug label specifications.", "recall_initiation_date": "20220629", "center_classification_date": "20220805", "termination_date": "20240213", "report_date": "20220817", "code_info": "", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090070"], "brand_name": ["DIVALPROEX SODIUM"], "generic_name": ["DIVALPROEX SODIUM"], "manufacturer_name": ["Dr. Reddy's Laboratories Ltd"], "product_ndc": ["55111-534"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DIVALPROEX SODIUM"], "rxcui": ["1099569"], "spl_id": ["0d557d96-7ebb-86b3-bdd1-af0b959bc845"], "spl_set_id": ["fa823ee0-0c69-6b85-da1e-9bb2e2150ea5"], "package_ndc": ["55111-534-30", "55111-534-60", "55111-534-01", "55111-534-05"], "is_original_packager": [true], "upc": ["0355111534013"], "unii": ["644VL95AO6"]}, "product_type": "Drugs", "event_id": "71374", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1136-2015", "product_description": "Divalproex Sodium Extended-Release Tablets, USP, 500 mg, 100 count bottles, Rx Only,  Mfd. By. Dr. Reddy's Laboratories Limited Bachupally 500 090 India --- NDC 55111-534-01", "product_quantity": "5,160 bottles", "reason_for_recall": "Failed Dissolution Specifications; exceeded specification at the 9 hour time point", "recall_initiation_date": "20150522", "center_classification_date": "20150612", "termination_date": "20170424", "report_date": "20150624", "code_info": "Lot #C308195, exp 10/2015", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-952-2013", "product_description": "DUAL-TESTOSTERONE 20, 50, 100, 150, 200 MG/ML OIL INJ SOLN, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "05302013@6, 02112013@5, 04192013@21, 05032013@14, 01252013@11, 03272013@17, 01252013@8, 03272013@22, 01312013@9, 06062013@24, 01032013@1, 01152013@14, 01292013@4, 01312013@10, 02142013@9, 03062013@10, 03112013@6, 03112013@4, 04042013@16, 04122013@18, 04302013@24, 05102013@18, 05282013@29, 06042013@18, 06282013@10, 07112013@21, 07232013@1, 07282013@1, 07282013@2, 01312013@8, 05222013@26.", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0727-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 25 mg/250 mL* (100 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-7011-1.", "product_quantity": "5304 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883924, Exp 05/02/2023; 37-884918, Exp 05/07/2023; 37-885677, Exp 05/09/2023; 37-887318, Exp 05/16/2023; 37-889211, Exp 05/23/2023; 37-889848, Exp 05/25/2023; 37-891150, Exp 05/31/2023; 37-892482, Exp 06/06/2023; 37-894484, Exp 06/13/2023; 37-896458, 37-896480, Exp 06/21/2023; 37-897967, Exp 06/27/2023; 37-898551, Exp 06/29/2023"}, {"status": "Terminated", "city": "Peoria", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72241", "recalling_firm": "Kalman Health & Wellness, Inc. dba Essential Wellness Pharma", "address_1": "4625 N University St", "address_2": "N/A", "postal_code": "61614-5828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-314-2016", "product_description": "Methylcobalamin 1 mg/mL (Pres Free) Injection, 1 mL prefilled syringes, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.", "product_quantity": "10 prefilled syringes", "reason_for_recall": "Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.", "recall_initiation_date": "20150903", "center_classification_date": "20151117", "termination_date": "20171229", "report_date": "20151125", "code_info": "Lot #: 072915, Exp 09/13/2015; 080415, Exp 09/19/2015; and 1345-081815, Exp 10/03/2015"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211892"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-440", "16729-441", "16729-442"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["40aa0834-3fd8-c230-e063-6294a90a800d"], "spl_set_id": ["6bad4e06-c0a1-4123-83c2-67d3b081e8a9"], "package_ndc": ["16729-440-10", "16729-440-15", "16729-440-01", "16729-441-10", "16729-441-15", "16729-441-01", "16729-442-10", "16729-442-15", "16729-442-01"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95501", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "N/A", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and PR", "recall_number": "D-0030-2025", "product_description": "Cinacalcet Tablets 30 mg, Rx Only, a) 30 Tablets per bottle, NDC: 16729-440-10, b) 90 Tablets per bottle, NDC: 16729-440-15, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, INDIA.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.", "recall_initiation_date": "20241010", "center_classification_date": "20241031", "report_date": "20241106", "code_info": "a) Lot #:             Expiry Date: M2118190        11/2024 M2201091        11/2024 M2206241             11/2024 M2206451             04/2025 M2208674             06/2025 M2213850             08/2025 M2215221             09/2025 M2216236             11/2025 M2217098             11/2025 M2300664             11/2025  b) Lot #:           Expiry Date: M2210808            06/2025 M2212212            08/2025 M2214435            09/2025 M2217097            11/2025 M2301921            01/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-968-2013", "product_description": "HYALURONIDASE  150 U/ML and 200 U/ML  INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "05312013@24, 04242013@34", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0801-2023", "product_description": "DOCU LIQUID (docusate sodium, 50 mg/5 mL), packaged in 473mL bottles and b)10mL Unit Dose cups,  Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Lakewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96792", "recalling_firm": "BSO LLC", "address_1": "12860 W Cedar Dr Ste 211", "address_2": "N/A", "postal_code": "80228-1971", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0414-2025", "product_description": "TESTOSTERONE PELLET 200 mg BLUNT (with Cholesterol </=2%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0124-01", "product_quantity": "355 vials", "reason_for_recall": "Presence of Particulate Matter: Glass particles were found in pellet vials.", "recall_initiation_date": "20250428", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot 20250217@7, exp 1/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0705-2019", "product_description": "Dr. King's SafeCare Rx Lymph Detox Cleansing & Detox, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 35795506329, NDC 57955-0339-2", "product_quantity": "1927 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 080315A Exp. 08/18; 030916K Exp. 03/19; 080916T Exp. 08/19; 020817G Exp. 02/20; 010118V Exp. 01/20"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71553", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1227-2015", "product_description": "Lisinopril tablets, USP 10mg packaged in 10-count blisters (NDC 68084-061-11); 10 blister packs per carton (NDC 68084-061-01); Rx only,  Manufactured by: Wockhardt Limited, Mumbai, India, Distributed by: Wockhardt, USA, LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA for American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217.", "product_quantity": "13,532 cartons", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150601", "center_classification_date": "20150708", "termination_date": "20170222", "report_date": "20150715", "code_info": "Lot#: 131933, Exp 07/31/2015"}, {"status": "Terminated", "city": "Madison", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86405", "recalling_firm": "pH-D Feminine Health", "address_1": "305 Williams Ave", "address_2": "N/A", "postal_code": "37115-2626", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1627-2020", "product_description": "pH-D Feminine Health Boric Acid Vaginal Suppositories, 24 vaginal suppositories per box, 600 mg each, pH-D Feminine Health, LLC Madison, TN 37115, UPC Code: 3 49597 00044 5.", "product_quantity": "a. 37,000 boxes; b. 45,000 boxes; c. 6,100 boxes", "reason_for_recall": "Marketed without an Approved NDA/ANDA.", "recall_initiation_date": "20200902", "center_classification_date": "20200930", "termination_date": "20220225", "report_date": "20201007", "code_info": "Lot #: a) 2PA20021, 2PA20061; b) D-160, D-155, D-162; c) 7PA20071."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: EXEMESTANE, Tablet, 25 mg may be potentially mislabeled as the following drug:   OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W003473, EXP: 6/20/2014.", "address_2": "", "product_quantity": "60 Tablets", "code_info": "EXEMESTANE, Tablet, 25 mg has the following codes:  Pedigree: W003471, EXP: 6/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "EXEMESTANE, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054008013.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-793-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: CANDESARTAN CILEXETIL, Tablet, 16 mg may have potentially been mislabeled as the following drug:  IRBESARTAN, Tablet, 150 mg, NDC 65862063830, Pedigree: W003649, EXP: 6/25/2014.", "address_2": "", "product_quantity": "30 Tablets", "code_info": "CANDESARTAN CILEXETIL, Tablet, 16 mg has the following codes:   Pedigree: W003611, EXP: 6/25/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CANDESARTAN CILEXETIL, Tablet, 16 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00186001631.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-882-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: guanFACINE HC, Tablet, 1 mg may have potentially been mislabeled as one of the following drugs:  glyBURIDE, Tablet, 2.5 mg, NDC 00093834301, Pedigree: AD46265_22, EXP: 5/15/2014;  FOSINOPRIL SODIUM, Tablet, 10 mg, NDC 60505251002, Pedigree: AD46414_19, EXP: 5/16/2014;  chlorproMAZINE HCl, Tablet, 100 mg, NDC 00832030300, Pedigree: AD70629_4, EXP: 5/29/2014;  guanFACINE HCl,", "address_2": "", "product_quantity": "500 Tablets", "code_info": "guanFACINE HC, Tablet, 1 mg has the following codes:   Pedigree: AD46265_25, EXP: 5/15/2014;  Pedigree: AD46414_22, EXP: 5/16/2014;  Pedigree: AD70629_7, EXP: 5/29/2014;  Pedigree: W003007, EXP: 6/12/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "guanFACINE HC, Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00378116001.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-895-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Rafelbunol", "state": "N/A", "country": "Spain", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73574", "recalling_firm": "Sesderma, SL", "address_1": "Calle Massamagrell 3-5", "address_2": "Poligono Industrial Rafelbunol", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Distributed to following states: FL, PR, CO, GA.", "recall_number": "D-0850-2016", "product_description": "Screenses Color Sunscreen Tinted facial make-up compact, Broad Spectrum SPF 50, Brown, 0.35 oz (10 g), Manufactured by Sesderma S.L., Valencia, Spain, UPC 8 429979 252166", "product_quantity": "45 compacts", "reason_for_recall": "cGMP Deviations; product does not comply with cGMP requirements", "recall_initiation_date": "20151015", "center_classification_date": "20160510", "report_date": "20160518", "code_info": "Lot code H-04, exp 07/2019"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1430 mL in Vials", "code_info": "Lot #: 160119-59; BUD: 05/26/16,  Lot #: 151228-72; BUD: 05/26/16,  Lot #: 160127-4; BUD: 05/26/16,  Lot #: 160201-13; BUD: 05/26/16,  Lot #: 160202-13; BUD: 05/26/16,  Lot #: 160204-11; BUD: 05/26/16,  Lot #: 160202-66; BUD: 06/11/16,  Lot #: 160307-31; BUD: 06/11/16,  Lot #: 160224-68; BUD: 06/11/16,  Lot #: 160205-8; BUD: 06/11/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "M.I.C B-COMPLEX W/PRES. (BENZYL ETOH 2%)  B1-50MG;B2-5-PO4-5MG;B3-50MG;B5-5MG;B6-5MG;  CYANO B12 100MCG; CHOLINE CHL-50MG;  INOSITOL-25MG;METHIONINE 12.5MG/ML, 5ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1223-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waterford", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79149", "recalling_firm": "American Pharmaceutical Ingredients LLC", "address_1": "6650 Highland Rd Ste 302", "address_2": "N/A", "postal_code": "48327-1665", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within USA.", "recall_number": "D-0496-2018", "product_description": "Imiquimod USP for prescription compounding, packaged in a) 1g (NDC 58597-8317-1); b) 10g (NDC 58597-8317-3); c)  25g (NDC 58597-8317-4)  RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327", "product_quantity": "1638 g", "reason_for_recall": "CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.", "recall_initiation_date": "20180209", "center_classification_date": "20180222", "termination_date": "20191202", "report_date": "20180228", "code_info": "Lot #: a)  012016-2, Exp. 11/30/2020; b) 012016-1, Exp. 11/30/2020;  c) 012016-1, Exp. 11/30/2020;  012016-2, Exp.11/30/2020;"}, {"status": "Terminated", "city": "Highland", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89334", "recalling_firm": "ULTRAtab Laboratories, Inc.", "address_1": "50 Toc Dr", "address_2": "N/A", "postal_code": "12528-1506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Bulk product was distributed to 3 distributors who may have distributed finished product.", "recall_number": "D-0533-2022", "product_description": "Normed APAP 325 mg (Acetaminophen 325 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-203-00", "product_quantity": "3,667,885 tablets", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20220126", "center_classification_date": "20220209", "termination_date": "20250107", "report_date": "20220216", "code_info": "Product Codes: L203L  Bulk Lots: 18K012, 19E091"}, {"status": "Terminated", "city": "Conway", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72179", "recalling_firm": "US Compounding Inc", "address_1": "1270 Don's Lane", "address_2": "N/A", "postal_code": "72032", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0290-2016", "product_description": "Tropicamide 1%/Phenylephrine 2.5% (tropicamide USP 10 mg/ phenylephrine HCL USP 25 mg), 10 mL Ophthalmic Dropper, For Topical Ophthalmic Use, Rx only, Compounded by US Compounding Pharmacy, Conway, Arkansas, 72032, NDC 62295-3214-07", "product_quantity": "751 bottles", "reason_for_recall": "Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.", "recall_initiation_date": "20150912", "center_classification_date": "20151117", "termination_date": "20170330", "report_date": "20151125", "code_info": "Lot Code: 20151307@4 BUD: 1/9/2016, 20151805@30 BUD: 11/14/2015, 20152004@23 BUD: 10/17/2015"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0769-2020", "product_description": "SUFENTANIL 55.5 MCG/ML IN 18ML  INJ in 18 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12122019@19 Exp. 12/21/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Wakefield", "state": "RI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88070", "recalling_firm": "World Source Llc", "address_1": "145 Oakwoods Dr", "address_2": "", "postal_code": "02879-2512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two hospitals in NY.", "recall_number": "D-0632-2021", "product_description": "QiYu Hand Sanitizer Gel, ethanol, 500 mL bottles (pump), Manufacturer Guangzhou Minghui Cosmetics Co., Ltd., Baiyun District, Guanzhou", "product_quantity": "6,300 bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20210609", "center_classification_date": "20210616", "termination_date": "20220609", "report_date": "20210623", "code_info": "Manufacturer's lot # 20200320, exp. date March 2022  WorldSource LLC, Item # TCM004", "more_code_info": ""}, {"status": "Terminated", "city": "St Petersburg", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "77899", "recalling_firm": "International Laboratories, Inc.", "address_1": "2701 75th St N", "address_2": "N/A", "postal_code": "33710-2938", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. nationwide and Puerto Rico", "recall_number": "D-0102-2018", "product_description": "Pravastatin Sodium Tablets, USP, 40 mg, 30-count bottle, Rx only, Packaged for: International Laboratories, LLC. St. Petersburg, FL 33710, NDC 54458-925-16", "product_quantity": "82056 bottles", "reason_for_recall": "Labeling: Label mix-up, the product labeled as Pravastatin sodium tablets 40 mg was filled with Bupropion hydrochloride XL Tablets 300 mg.", "recall_initiation_date": "20170807", "center_classification_date": "20171201", "termination_date": "20190502", "report_date": "20171213", "code_info": "Lot # 115698A, Exp 02/19", "more_code_info": ""}, {"country": "United States", "city": "Orlando", "address_1": "6700 Conroy Windermere Rd", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "address_2": "Suite 140", "product_quantity": "2", "code_info": "B5426 Exp 8/26/13 and A5110 Exp 12/1/13", "center_classification_date": "20130711", "distribution_pattern": "Nationwide and PR", "state": "FL", "product_description": "Meloxicam 5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL", "report_date": "20130717", "classification": "Class II", "openfda": {}, "recalling_firm": "Lowlite Investments, Inc. D/B/A Olympia Pharmacy", "recall_number": "D-752-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "65360", "recall_initiation_date": "20130529", "postal_code": "32835-3500", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "San Francisco", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73662", "recalling_firm": "Reliable Rexall-A Compounding Pharmacy", "address_1": "801 Irving St", "address_2": "N/A", "postal_code": "94122-2310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Including: CA, HI, NM", "recall_number": "D-1127-2016", "product_description": "All methyltestosterone Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.", "product_quantity": "N/A", "reason_for_recall": "Lack of Processing Controls", "recall_initiation_date": "20160325", "center_classification_date": "20160706", "termination_date": "20170410", "report_date": "20160713", "code_info": "All lots compounded between 03/24/2015 and 03/24/2016 and within expiry."}, {"status": "Terminated", "city": "Colonia", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83427", "recalling_firm": "Colonia Care Pharmacy", "address_1": "515 Inman Ave Ste A", "address_2": "N/A", "postal_code": "07067-1114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Patient Specific Prescriptions in NJ", "recall_number": "D-0023-2020", "product_description": "C-PAPAV/PHENTOL/PGE1 18MG/0.6MG/11.8MCG/ML, 10 mL vial, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067", "product_quantity": "1 vial", "reason_for_recall": "Lack of Assurance of Sterility: product sterility cannot be guaranteed.", "recall_initiation_date": "20190724", "center_classification_date": "20191001", "termination_date": "20230405", "report_date": "20191009", "code_info": "Lot #: 062719E, BUD 08/11/19"}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "4 Bags", "code_info": "Compounded on 05/29/15, Discard After: 06/12/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "Penicillin G Potassium 5.4 MU/SW 240 mL AccuFlo, Qty: 4 240 mL Bags, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1166-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93339", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0108-2024", "product_description": "Lubricating Tears Eye Drops (Dextran/Hypromellose), 0.1%/0.3%, packaged in 0.5 FL OZ (15mL) bottles, Distributed by: RUGBY LABORATORIES, Livonia, MI 48152, NDC 0536-1282-94", "product_quantity": "65,880 bottles", "reason_for_recall": "Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling  at the manufacturing facility.", "recall_initiation_date": "20231031", "center_classification_date": "20231117", "termination_date": "20250415", "report_date": "20231129", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0058-2019", "product_description": "Best Choice, 12 Hour No-Drip Nasal Spray (Oxymetazoline Hydrochloride 0.05%) Nasal Decongestant, 1 FL OZ (30 mL) bottle, Proudly Distributed By: Valu Merchandisers, Co., 5000 Kansas Ave, Kansas City, KS 66106, UPC 0 70038 59895 4.", "product_quantity": "3,600 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "358000 mL in Vials", "code_info": "a) Lot #: 151201-30, BUD: 05/29/16;  Lot #: 151209-26, BUD: 06/06/16;  Lot #: 151216-63, BUD: 06/13/16;  Lot #: 151231-11, BUD: 06/28/16;  Lot #: 160105-4, BUD: 07/03/16;  Lot #: 160125-41, BUD: 07/23/16;  Lot #: 160211-20, BUD: 08/09/16.  b) Lot #: 151201-30, BUD: 05/29/16;  Lot #: 151209-26, BUD: 06/06/16;  Lot #: 151216-63, BUD: 06/13/16;  Lot #: 151231-11, BUD: 06/28/16;  Lot #: 160105-4, BUD: 07/03/16;  Lot #: 160125-41, BUD: 07/23/16;  Lot #: 160511-20, BUD: 08/09/16.  c) Lot #: 151201-30, BUD: 05/29/16;  Lot #: 151209-26, BUD: 06/06/16;  Lot #: 151216-63, BUD: 06/13/16;  Lot #: 151231-11, BUD: 06/28/16;  Lot #: 160105-4, BUD: 07/03/16;  Lot #: 160125-41, BUD: 07/23/16;  Lot #: 160511-20, BUD: 08/09/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "NA ASCORBATE 500MG/ML NON-CORN (PF), In a) 10ML Vials,  b) 50ML Vials, and c) 100ML Vials,  MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1229-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83875", "recalling_firm": "Sandoz, Inc", "address_1": "506 Carnegie Ctr Ste 400", "address_2": "N/A", "postal_code": "08540-6243", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0129-2020", "product_description": "Sandoz Ranitidine Hydrochloride Capsules 300mg 30 Capsules Rx Only Manufactured by Sandoz Inc. Princeton, NJ 08540 Product of India  NDC 0781-2865-31", "product_quantity": "136,788 bottles", "reason_for_recall": "CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).", "recall_initiation_date": "20190923", "center_classification_date": "20191007", "termination_date": "20230714", "report_date": "20191016", "code_info": "HD8625 4/30/2020  HD9275 4/30/2020  HU2207 8/31/2020  HX6676 3/31/2021  HX6677 3/31/2021"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73537", "recalling_firm": "Meditech Laboratories, Inc", "address_1": "3200 Polaris Ave Ste 27", "address_2": "N/A", "postal_code": "89102-8379", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0802-2016", "product_description": "Formula 2 (Papaverine 9 mg, Phentolamine 1 mg, Atropine 0.1 mg, PGE 10 mcg/mL) Injection, 5 mL vials, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV  89102.", "product_quantity": "1320 vials - all formulas", "reason_for_recall": "Superpotent Drug: one ingredient was found to be above assay specification.", "recall_initiation_date": "20160314", "center_classification_date": "20160401", "termination_date": "20160607", "report_date": "20160413", "code_info": "Lot #: 110115-2, Exp 01/01/16", "more_code_info": ""}, {"status": "Ongoing", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA213510"], "brand_name": ["DOCETAXEL"], "generic_name": ["DOCETAXEL ANHYDROUS"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-254"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DOCETAXEL ANHYDROUS"], "rxcui": ["1093280"], "spl_id": ["841e3024-e160-4c4b-93d3-1e79d628d95b"], "spl_set_id": ["6b227144-c844-4549-960c-cc3ac5c13b2b"], "package_ndc": ["25021-254-08", "25021-254-16"], "is_original_packager": [true], "nui": ["N0000175085", "N0000175592"], "pharm_class_pe": ["Microtubule Inhibition [PE]"], "pharm_class_epc": ["Microtubule Inhibitor [EPC]"], "unii": ["699121PHCA"]}, "product_type": "Drugs", "event_id": "94707", "recalling_firm": "Sagent Pharmaceuticals", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0553-2024", "product_description": "Docetaxel Injection, USP, 80 mg per 8 mL (10 mg per mL), 1 x 8 mL Multi-Dose Vial, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195 (USA), Made in India. NDC 25021-254-08", "product_quantity": "762 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.", "recall_initiation_date": "20240528", "center_classification_date": "20240612", "report_date": "20240619", "code_info": "Lot #: F1040001, Exp. Date 12/31/2024"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0374-2020", "product_description": "CVS Health Lubricant Eye Drops for  Mild to Moderate Dry Eye, Sterile, 0.5 Fl. oz. (15 mL), Item #317916, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895", "product_quantity": "365,832 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: 17196 08/19  17192 09/19  17355 11/19  18024 01/20  18036 02/20  18237 09/20  18293 12/20  18105 04/20  18179 07/20  19040 2/21"}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95993", "recalling_firm": "Hikma Injectables USA Inc", "address_1": "36 Stults Rd", "address_2": "", "postal_code": "08810-1540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0174-2025", "product_description": "phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25", "product_quantity": "", "reason_for_recall": "Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.", "recall_initiation_date": "20241219", "center_classification_date": "20250102", "termination_date": "20251112", "report_date": "20250108", "code_info": "Lot number: 243120003D, Use by Date: 03/11/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0750-2019", "product_description": "Dr. King's SafeCare Rx Sexual Identity Mind & Body, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955127024, NDC 57955-1271-2", "product_quantity": "2 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 021717C Exp. 02/20"}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0304-2022", "product_description": "EPINEPHrine, 2 mg per 250 mL (8 mcg per mL) in 0.9% Sodium Chloride Injection, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY, 12903, NDC 70324-027-01.", "product_quantity": "2779 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21257/BXC", "more_code_info": ""}, {"status": "Terminated", "city": "Schaumburg", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209967"], "brand_name": ["PHENYLEPHRINE HYDROCHLORIDE"], "generic_name": ["PHENYLEPHRINE HYDROCHLORIDE"], "manufacturer_name": ["Sagent Pharmaceuticals"], "product_ndc": ["25021-315"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1232651", "1666372"], "spl_id": ["045c8994-a54f-4b5c-8b70-7cf7c962a59f"], "spl_set_id": ["b3ff0d1d-6f3f-4e3c-9407-6f3bf3a61e7d"], "package_ndc": ["25021-315-01", "25021-315-99", "25021-315-98"], "is_original_packager": [true], "unii": ["04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "87492", "recalling_firm": "Sagent Pharmaceuticals Inc", "address_1": "1901 N Roselle Rd Ste 450", "address_2": "N/A", "postal_code": "60195-3194", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0305-2021", "product_description": "Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL  60195; Made in India, NDC: 25021-315-01.", "product_quantity": "3716 cartons", "reason_for_recall": "Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.", "recall_initiation_date": "20210311", "center_classification_date": "20210317", "termination_date": "20221228", "report_date": "20210324", "code_info": "Lots: PHT8IB2, PHT9IB2, exp 08/2022; PHT1JB2, exp 09/2022"}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91038", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "N/A", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0063-2023", "product_description": "Carvedilol Tablets, USP, 25 mg, 500-count bottles, Rx Only, Mfg: Mylan Pharmaceuticals Inc. Morgantown, WV 36505, Made in India, NDC 0378-3634-05", "product_quantity": "2,794 bottles", "reason_for_recall": "Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.", "recall_initiation_date": "20221021", "center_classification_date": "20221116", "termination_date": "20230713", "report_date": "20221123", "code_info": "Lot #: 3150116, Exp 2/2025"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "20", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Fentanyl Citrate 2mcg/mL & Ropivacaine HCI 0.2% in 0.9% Sodium Chloride, 100 mL bag, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 5183-0906-48", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1320-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA016968"], "brand_name": ["MIOSTAT"], "generic_name": ["CARBACHOL"], "manufacturer_name": ["Alcon Laboratories, Inc."], "product_ndc": ["0065-0023"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBACHOL"], "rxcui": ["308966", "991606"], "spl_id": ["a76a34d0-2e07-408d-a8c8-d00f2715cad7"], "spl_set_id": ["f28d7a56-e079-4a8b-ad81-9a97c780de67"], "package_ndc": ["0065-0023-15"], "is_original_packager": [true], "unii": ["8Y164V895Y"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1036-2022", "product_description": "MIOSTAT (Carbachol Intraocular Solution, USP) 0.01%, 1.5 mL, Rx only, MFG: Alcon Surgical Inc., NDC 0065-0023-15", "product_quantity": "8 boxes/12 vials each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73830", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-0955-2016", "product_description": "Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient, DMF No. 15931; Manufactured by: Lupin Limited, Unit-1, 198-202, New Industrial Area No. 2, Dist. Raisen, Mandideep-462 046, (Madhya Pradesh) India; Regd. Office: 159, CST Road Kalina, Santacruz (E), Mumbai- 400 098, (Maharashtra) India.", "product_quantity": "741.171 kg", "reason_for_recall": "CGMP Deviations: active pharmaceutical ingredient intermediates failed specifications.", "recall_initiation_date": "20160311", "center_classification_date": "20160602", "termination_date": "20170814", "report_date": "20160608", "code_info": "Lot #: B4000935, Exp 01/17; B4005178, Exp 06/17; B4008730, B4008729, B4008727, B4008724, Exp 10/17; B5001647, B5001648, B5001649, Exp 02/18"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1810-2019", "product_description": "RITUXIMAB 575 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB 675 MG / 250 ml 0.9% NACL IVPB; RITUXIMAB  1000 MG / 1000 ml NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Dayton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83581", "recalling_firm": "Aurolife Pharma, LLC", "address_1": "2400 US Highway 130", "address_2": "N/A", "postal_code": "08810-1519", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1864-2019", "product_description": "Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed by: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ  08648, NDC 58602-711-21", "product_quantity": "8,240 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20190823", "center_classification_date": "20190917", "termination_date": "20220816", "report_date": "20190925", "code_info": "Lot #: 067180008A, Exp 03/21"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0052-2022", "product_description": "VIT B COMPLEX INJ SOLN (HP), Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Deerfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020678"], "brand_name": ["CLINIMIX E"], "generic_name": ["LEUCINE, PHENYLALANINE, LYSINE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, SERINE, TYROSINE, DIBASIC POTASSIUM PHOSPHATE, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, DEXTROSE"], "manufacturer_name": ["Baxter Healthcare Company"], "product_ndc": ["0338-0202", "0338-1142", "0338-1144", "0338-1113", "0338-1145", "0338-1115", "0338-1147", "0338-1123", "0338-1125", "0338-1148", "0338-0206", "0338-0210", "0338-0214", "0338-7020", "0338-7022", "0338-7024", "0338-7026", "0338-7028", "0338-7030", "0338-7032", "0338-7034", "0338-7036"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ALANINE", "ARGININE", "CALCIUM CHLORIDE", "DEXTROSE", "GLYCINE", "HISTIDINE", "ISOLEUCINE", "LEUCINE", "LYSINE", "MAGNESIUM CHLORIDE", "METHIONINE", "PHENYLALANINE", "POTASSIUM PHOSPHATE, DIBASIC", "PROLINE", "SERINE", "SODIUM CHLORIDE", "THREONINE", "TRYPTOPHAN", "TYROSINE", "VALINE"], "rxcui": ["800998", "801000", "801010", "801012", "801019", "801021", "801029", "801031", "1090635", "1090639"], "spl_id": ["dc7ce216-a4a9-41cf-80e3-5e901b8cecdf"], "spl_set_id": ["8469d6fb-d6ef-476f-8cc3-0905192de0a8"], "package_ndc": ["0338-1142-03", "0338-1144-03", "0338-1113-04", "0338-1145-03", "0338-1115-04", "0338-1147-03", "0338-1123-04", "0338-1125-04", "0338-1148-03", "0338-0202-01", "0338-0202-06", "0338-0206-01", "0338-0206-04", "0338-0210-01", "0338-0210-06", "0338-0214-01", "0338-0214-04", "0338-7020-01", "0338-7020-06", "0338-7022-01", "0338-7022-06", "0338-7024-01", "0338-7024-04", "0338-7026-01", "0338-7026-06", "0338-7028-01", "0338-7028-04", "0338-7030-01", "0338-7030-06", "0338-7032-01", "0338-7032-04", "0338-7034-01", "0338-7034-06", "0338-7036-01", "0338-7036-04"], "is_original_packager": [true], "nui": ["N0000175780", "M0000922"], "pharm_class_epc": ["Amino Acid [EPC]"], "pharm_class_cs": ["Amino Acids [CS]"], "unii": ["9DLQ4CIU6V", "47E5O17Y3R", "2ZD004190S", "IY9XDZ35W2", "AE28F7PNPL", "TE7660XO1C", "M4I0D6VV5M", "GMW67QNF9C", "K3Z4F929H6", "452VLY9402", "451W47IQ8X", "CI71S98N1Z", "8DUH1N11BX", "42HK56048U", "4550K0SC9B", "OF5P57N2ZX", "94ZLA3W45F", "HG18B9YRS7", "02F3473H9O", "04Y7590D77", "4QD397987E"]}, "product_type": "Drugs", "event_id": "69868", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "1 Baxter Pkwy", "address_2": "N/A", "postal_code": "60015-4625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0301-2015", "product_description": "Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections, in CLARITY Dual Chamber Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-1115-04", "product_quantity": "7,220 bags", "reason_for_recall": "Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal", "recall_initiation_date": "20141125", "center_classification_date": "20141216", "termination_date": "20151028", "report_date": "20141224", "code_info": "Product Code 2B7717 Lot # P311357, exp 12/31/2015"}, {"status": "Terminated", "city": "Nixa", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90644", "recalling_firm": "Aire-Master of America Inc", "address_1": "1821 N State Highway Cc", "address_2": "", "postal_code": "65714-8015", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida, Illinois, Iowa, New Jersey", "recall_number": "D-1357-2022", "product_description": "Stage 2-Ophardt Foaming Hand Sanitizer, Fragrance-Free, 1000 mL (33.9 fl. oz.) per bottle, Manufactured for 2XL Corporation, 2 Gateway Ct, Ste A, Bolingbrook, IL 60440", "product_quantity": "4,632 cartons", "reason_for_recall": "CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.", "recall_initiation_date": "20220715", "center_classification_date": "20220818", "termination_date": "20230219", "report_date": "20220824", "code_info": "Product Number 46101, Lots 722712-exp 07/22, 724755-exp 11/22, 725054-exp 12/22", "more_code_info": ""}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0489-2022", "product_description": "SINU-PHEN PLUS sinus pain and congestion tabs (acetaminophen 500 mg, Phenylephrine HCl 5.0 mg) 2 tablet packets, Manufactured for: Tellus Medical Products, Palm Desert, CA 92211, NDC 69103-2536-00", "product_quantity": "122,400 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: AK9766, Exp. Date 08/2022"}, {"status": "Ongoing", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85781", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-1343-2020", "product_description": "amneal Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, Rx Only, 100 count bottles, Distributed by: Amneal Pharmaceuticals LLC Bridgewater, NJ 08807  NDC 53746-0178-01", "product_quantity": "192", "reason_for_recall": "CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level", "recall_initiation_date": "20200529", "center_classification_date": "20200625", "report_date": "20200701", "code_info": "HA07419A 1/31/2021  HB00119A 1/31/2021  HB00219A 1/31/2021  HB00319A 1/31/2021;  HB00419A 2/28/2021  HB00519A 2/28/2021  HB00619A 2/28/2021  HB00719A 2/28/2021  HB00819A 2/28/2021  HB00919A 2/28/2021  HB01019A 2/28/2021  HB05119A 2/28/2021  HB05219A 2/28/2021  HB05319A 2/28/2021  HB05419A 2/28/2021  HB05519A 2/28/2021  HB09519A 2/28/2021  HB09619A 2/28/2021  HB09719A 2/28/2021  HB09819A 2/28/2021  HB09919A 2/28/2021;   HC08219A 3/31/2021  HC08319A 3/31/2021  HC08419A 3/31/2021  HC08519A 3/31/2021  HC09019A 3/31/2021  HC09119A 3/31/2021  HC09219A 3/31/2021  HC09319A 3/31/2021  HC09419A 3/31/2021;   HD03419B 4/30/2021  HD03519B 4/30/2021  HD03619B 4/30/2021  HD03719B 4/30/2021  HD03819B 4/30/2021  HD03919B 4/30/2021  HD04019B 4/30/2021  HD04119B 4/30/2021  HD04219A 4/30/2021  HD05819A 4/30/2021  HD05919A 4/30/2021  HD06019A 4/30/2021  HD06119A 4/30/2021  HD06219A 4/30/2021  HD06319A 4/30/2021  HD06419A 4/30/2021  HD09019A 4/30/2021  HD09119A 4/30/2021  HD09219A 4/30/2021  HE01219B 4/30/2021  HE01319B 4/30/2021  HE01419B 4/30/2021  HE01519B 4/30/2021;   HE01619A 5/31/2021  HE01719A 5/31/2021  HE01819A 5/31/2021  HE04419A 5/31/2021  HE04519A 5/31/2021  HE04619A 5/31/2021  HE04719A 5/31/2021  HE04819A 5/31/2021  HE04919A 5/31/2021  HE05019A 5/31/2021  HE05119A 5/31/2021  HE05219A 5/31/2021  HE05319A 5/31/2021  HE07219A 5/31/2021  HE07319A 5/31/2021  HE07419A 5/31/2021  HE07519A 5/31/2021  HE07619A 5/31/2021  HF02219A 5/31/2021  HF02319A 5/31/2021;  HF02419A 6/30/2021  HF02519A 6/30/2021  HF02619A 6/30/2021  HF02719A 6/30/2021  HF02819A 6/30/2021  HF02919A 6/30/2021  HF03019A 6/30/2021  HF03119A 6/30/2021  HF03219A 6/30/2021  HF03319A 6/30/2021  HF05419A 6/30/2021;  HF03918A 6/30/2020  HF04018A 6/30/2020  HF04118A 6/30/2020  HF04218A 6/30/2020  HF04318A 6/30/2020  HF04418A 6/30/2020  HF06518A 6/30/2020  HF06818B 6/30/2020  HF06918B 6/30/2020  HF07018B 6/30/2020  HF07118B 6/30/2020  HF07218A 6/30/2020  HF07318A 6/30/2020  HF07418A 6/30/2020  HF08318A 6/30/2020  HF08418A 6/30/2020  HF08518A 6/30/2020;  HF11219A 6/30/2021  HF11319A 6/30/2021  HF11419A 6/30/2021  HF11519A 6/30/2021  HF11619A 6/30/2021  HF11719A 6/30/2021  HF11819A 6/30/2021  HF11919A 6/30/2021  HF12019A 6/30/2021  HG00719A 6/30/2021  HG00819A 6/30/2021  HG00919A 6/30/2021  HG01019A 6/30/2021  HG01119A 6/30/2021  HG01219A 6/30/2021  HG01319A 6/30/2021  HG01419A 6/30/2021;  HG01519A 7/31/2021  HG01619A 7/31/2021  HG02919A 7/31/2021  HG03019A 7/31/2021  HG03119A 7/31/2021  HG03219A 7/31/2021  HG03319A 7/31/2021  HG03419A 7/31/2021  HG03519A 7/31/2021  HG03619A 7/31/2021  HG03719A 7/31/2021  HG03819A 7/31/2021;  HH08218A 8/31/2020  HH08318A 8/31/2020  HH08418A 8/31/2020  HH08518A 8/31/2020  HH08618A 8/31/2020  HH08718A 8/31/2020  HH08818A 8/31/2020  HH08918A 8/31/2020  HH09018A 8/31/2020  HH09118A 8/31/2020  HH09218A 8/31/2020  HH09318A 8/31/2020  HH09418A 8/31/2020  HH09518A 8/31/2020  HH09618A 8/31/2020  HH11218A 8/31/2020  HH11318A 8/31/2020  HH11418A 8/31/2020  HH11518A 8/31/2020;  HH11618A 9/30/2020  HH11718A 9/30/2020  HJ04818A 9/30/2020  HJ04918A 9/30/2020  HJ08518A 9/30/2020;  HJ08618A 10/31/2020  HJ08718A 10/31/2020  HJ08818A 10/31/2020  HJ08918A 10/31/2020  HJ09018A 10/31/2020  HJ09118A 10/31/2020  HK03718A 10/31/2020  HK03818A 10/31/2020  HK03918A 10/31/2020  HK04018A 10/31/2020  HK04118A 10/31/2020  HK04218A 10/31/2020  HK04318A 10/31/2020  HK04418A 10/31/2020  HK04518A 10/31/2020  HK04618A 10/31/2020  HK09318A 10/31/2020  HK09418A 10/31/2020  HK09518A 10/31/2020  HK09618A 10/31/2020  HK09718A 10/31/2020;  HM00218A 12/31/2020  HM00318A 12/31/2020  HM00418A 12/31/2020  HM00518A 12/31/2020  HM00618B 12/31/2020  HM00718B 12/31/2020  HM00818B 12/31/2020  HM00918B 12/31/2020  HM01018B 12/31/2020;  HM02918A 1/31/2021  HM03018A 1/31/2021  HM03218A 1/31/2021  HM03318A 1/31/2021  HM03418A 1/31/2021  HM03518A 1/31/2021  HM03618A 1/31/2021  HM03718A 1/31/2021  HM03818A 1/31/2021"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0973-2020", "product_description": "MIC-B12 Injection, MIC-B12 25MG/50MG/50MG/1MG/ML INJECTABLE, For IM Use, Refrigerate. Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0230-3", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07102019+52618, Exp 2/8/2020; 09052019+52880, Exp 4/5/2020; 10012019+52983, Exp 5/1/2020; 11052019+53188, Exp 6/5/2020; 12112019+53367, Exp 7/11/2020"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0152-2016", "product_description": "TRIMIX, injectable Solution, 40MG/2MG/40MCG/ML, syringe size: 10mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "3 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t02272015@24, t04272015@22, t06022015@4."}, {"country": "United States", "city": "Olive Branch", "address_1": "1 & 2", "reason_for_recall": "Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.", "address_2": "154 Downing Street", "product_quantity": "Unknown", "code_info": "Lot #: 15917VP03, 15917VP02, 15917VP01, Exp 10/31/2019; 15918004, 15918003, 15918002, 15918001, Exp 12/31/2019; 15918VP03, 15918VP02, 15918VP01, 15918005, Exp 2/29/2020; 15918007, 15918006, Exp  3/31/2020.", "center_classification_date": "20180907", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "state": "MS", "product_description": "Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-159-04.", "report_date": "20180829", "classification": "Class I", "openfda": {}, "recalling_firm": "Westminster Pharmaceuticals LLC", "recall_number": "D-1181-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80719", "termination_date": "20200603", "more_code_info": "", "recall_initiation_date": "20180803", "postal_code": "38654", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "6 units", "code_info": "Rx #'s:   0405733    0353173    0349837    0392673", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "DMPS 250MG/10ML INJECTABLE 20 ML, 30 ML; DMPS 50MG/ML (500MG/10ML) INJECTABLE 10 ML, 5 ML (4 DIFFERENT PRODUCTS)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1504-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Chesterbrook", "address_1": "1300 Morris Dr", "reason_for_recall": "Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.", "address_2": "", "product_quantity": "49 vials", "code_info": "Lot #s: 7800932, 7800933, exp 02/15", "center_classification_date": "20130927", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "Ifosfamide Injection 1g/20mL, Single dose vial, Rx only, Sterile, For Intravenous Use,  Refrigerate at 2-8 degrees celcius, Distributed by Pfizer Labs, Division of Pfizer Inc., New York, NY 10017, NDC 0069-4495-22", "report_date": "20131009", "classification": "Class II", "openfda": {}, "recalling_firm": "AmeriSource Bergen", "recall_number": "D-1065-2013", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "66316", "termination_date": "20141001", "more_code_info": "", "recall_initiation_date": "20130913", "postal_code": "19087-5559", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "El Paso", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87592", "recalling_firm": "CareFusion 213, LLC", "address_1": "1550 Northwestern Dr", "address_2": "N/A", "postal_code": "79912-8000", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA and to Singapore, Chile, Oman, Columbia, United Arab Emirates, South Africa, Kuwait, Democratic Republic of the Congo, Qatar, Bahrain, Hong Kong, Brazil.", "recall_number": "D-0346-2021", "product_description": "ChloraPrep With Tint 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Non-Sterile Solution - Hi-Lite Orange, 0.10 fl. oz. (3 ml) each, 25 applicators in carton, applicator is sterile if package is intact. CareFusion El Paso, TX 79912, NDC 054365-400-11 Cat. No. 260415", "product_quantity": "6,869,400 cartons", "reason_for_recall": "Microbial Contamination of Non-Sterile Product:.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.", "recall_initiation_date": "20210319", "center_classification_date": "20210426", "termination_date": "20220929", "report_date": "20210505", "code_info": "Lot and Exp Date:  0011737, 1/31/2023;  0020739, 1/31/2023;  0023790, 1/31/2023;  0037278, 1/31/2023;  0037279, 1/31/2023;  0038209, 1/31/2023;  0044734, 12/31/2022;  0007625, 10/31/2022;  0007630, 12/31/2022;  8095632, 3/31/2021;  8116723, 4/30/2021;  8127657, 4/30/2021;  8135651, 5/31/2021;  8137527, 5/31/2021;  8151741, 5/31/2021;  8158638, 5/31/2021;  8164530, 6/30/2021;  8178658, 6/30/2021;  8193779, 6/30/2021;  8197517, 6/30/2021;  8198765, 7/31/2021;  8212881, 7/31/2021;  8220737, 7/31/2021;  8226561, 7/31/2021;  8235991, 8/31/2021;  8249940, 8/31/2021;  8295569, 10/31/2021;  8304501, 10/31/2021;  8304849, 10/31/2021;  8306694, 10/31/2021;  8311791, 10/31/2021;  8334983, 11/30/2021;  8347719, 11/30/2021;  9008965, 12/31/2021;  9011841, 12/31/2021;  9031893, 1/31/2022;  9037824, 1/31/2022;  9038599, 1/31/2022;  9042938, 1/31/2022;  9044573, 1/31/2022;  9045831, 2/28/2022;  9051563, 2/28/2022;  9052565, 2/28/2022;  9053560, 2/28/2022;  9058847, 2/28/2022;  9059821, 2/28/2022;  9067665, 2/28/2022;  9072856, 2/28/2022;  9086532, 3/31/2022;  9087985, 3/31/2022;  9122538, 4/30/2022;  9126562, 4/30/2022;  9126564, 4/30/2022;  9137903, 5/31/2022;  9137904, 5/31/2022;  9154908, 5/31/2022;  9168975, 6/30/2022;  9171618, 6/30/2022;  9191256, 6/30/2022;  9218464, 7/31/2022;  9218595, 7/31/2022;  9221444, 7/31/2022;  9228305, 8/31/2022;  9241932, 8/31/2022;  9247742, 8/31/2022;  9249471, 8/31/2022;  9257903, 8/31/2022;  9263093, 9/30/2022;  9267133, 9/30/2022;  9269603, 9/30/2022;  9282881, 9/30/2022;  9284875, 9/30/2022;  9284881, 9/30/2022;  9289669, 9/30/2022;  9290455, 10/31/2022;  9291279, 10/31/2022;  9295914, 10/31/2022;  9296395, 10/31/2022;  9305775, 11/30/2022;  9311076, 2/28/2023;  9316348, 10/31/2022;  9317310, 11/30/2022;  9317312, 11/30/2022;  9324565, 11/30/2022;  9337530, 11/30/2022;  9341852, 11/30/2022;  9345911, 11/30/2022;  0098528, 12/31/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA086223"], "brand_name": ["ISOSORBIDE DINITRATE"], "generic_name": ["ISOSORBIDE DINITRATE"], "manufacturer_name": ["Sandoz Inc."], "product_ndc": ["0781-1556", "0781-1635", "0781-1695"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ISOSORBIDE DINITRATE"], "rxcui": ["206842", "314055", "381056"], "spl_id": ["9c848a4f-2720-4c80-a0be-e49200cb10f9"], "spl_set_id": ["71fdd147-a987-40b6-9f07-82d56525ceb8"], "package_ndc": ["0781-1635-10", "0781-1635-01", "0781-1635-13", "0781-1556-01", "0781-1556-05", "0781-1556-10", "0781-1556-13", "0781-1695-13", "0781-1695-10", "0781-1695-01"], "is_original_packager": [true], "upc": ["0307811556017", "0307811695013", "0307811635019"], "nui": ["N0000175415", "M0014874", "N0000009909"], "pharm_class_epc": ["Nitrate Vasodilator [EPC]"], "pharm_class_cs": ["Nitrates [CS]"], "pharm_class_pe": ["Vasodilation [PE]"], "unii": ["IA7306519N"]}, "product_type": "Drugs", "event_id": "81457", "recalling_firm": "Sandoz Inc", "address_1": "100 College Rd W", "address_2": "", "postal_code": "08540-6604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0258-2019", "product_description": "Isosorbide Dinitrate Tablets, USP 20 mg, 100-count bottles, Rx Only, Distributed by: Sandoz Inc. Princeton, NJ 08540; NDC 0781-1695-01", "product_quantity": "18,832 bottles", "reason_for_recall": "Cross Contamination with Other Products", "recall_initiation_date": "20181102", "center_classification_date": "20181120", "termination_date": "20201002", "report_date": "20181121", "code_info": "Lots: a) JA9535 Exp. 05/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Fairfield", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92786", "recalling_firm": "Parker Laboratories, Inc.", "address_1": "286 Eldridge Rd", "address_2": "N/A", "postal_code": "07004-2509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States, Singapore, Korea and Hong Kong", "recall_number": "D-1093-2023", "product_description": "Helix CBD Clinical Cream (Menthol 7.4%), packaged in a)3 gm pouches (NDC30775-054-01), b)2 fl. oz. tubes (NDC 30775-054-02), and c) 4 fl. oz. tubes (NDC 30775-054-04), Parker Laboratories, Inc. 286 Eldridge Road, Fairfield, NJ 07004", "product_quantity": "50", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230802", "center_classification_date": "20230818", "termination_date": "20240603", "report_date": "20230830", "code_info": "Lot #: a) J1121011, Exp. Date 12/21/2023, b) A0921009, Exp. Date 8/18/2023, c) A0921008, Exp. Date 8/18/2023"}, {"status": "Terminated", "city": "Canton", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "95427", "recalling_firm": "Fresenius Kabi Compounding, LLC", "address_1": "20 Dan Rd", "address_2": "N/A", "postal_code": "02021-2809", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 125 direct accounts nationwide.", "recall_number": "D-0018-2025", "product_description": "Vancomycin HCl 750 mg per 250 mL 0.9% Sodium Chloride Injection USP, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC 71506-014-58", "product_quantity": "1082 bags", "reason_for_recall": "cGMP violations", "recall_initiation_date": "20240925", "center_classification_date": "20241021", "termination_date": "20250815", "report_date": "20241030", "code_info": "Lot # C274-000038004, exp. date 27-Nov-24", "more_code_info": ""}, {"country": "United States", "city": "Jackson", "address_1": "N168w22223 Main St", "reason_for_recall": "cGMP violations", "address_2": "", "product_quantity": "44,373 cartons", "code_info": "Lot #:  a) 81827, Exp 8/2020; 111872, Exp 11/2020; 41970, Exp 4/2021; 519104, Exp 5/2021; b) 81827, Exp 8/2020; 111872, Exp 11/2020; 41970, Exp 4/2021.", "center_classification_date": "20200116", "distribution_pattern": "OR", "state": "WI", "product_description": "Yeast Arrest, Homeopathic Formula, Vaginal Support suppositories, packaged in a) 14-count carton (NDC 68093-0730-1 and 68093-0730-3), b) 28-count carton (NDC 68093-0730-2 and 68093-0730-4), Manufactured for: Vitanica, 12401 SW Leveton Drive, Tualatin, OR 97062.", "report_date": "20200122", "classification": "Class II", "openfda": {}, "recalling_firm": "Wisconsin Pharmacal Company, LLC", "recall_number": "D-0781-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84291", "termination_date": "20201106", "more_code_info": "", "recall_initiation_date": "20191114", "postal_code": "53037", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-795-2015", "product_description": "Mevastatin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0688-2020", "product_description": "BUP 1MG//ML/HYDROM 7MG  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12112019@10 Exp. 12/20/2019", "more_code_info": ""}]